Related Experiment Video
Updated: Jun 9, 2026
07:14
Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
Published on: May 23, 2025
Carcinomatous Meningitis from Unknown Primary Carcinoma
1Department of Medical Oncology, Center Georges Francois Leclerc, General Hospital, Dijon, France.
Case Reports in Oncology
|August 26, 2010
Summary
Carcinomatous meningitis (CM), a rare cancer complication, was diagnosed in a patient with no identifiable primary tumor. This case highlights the diagnostic challenges of CM from an unknown primary origin.
Area of Science:
- Neurology
- Oncology
- Pathology
Background:
- Carcinomatous meningitis (CM) affects 3-8% of cancer patients, often presenting with focal neurological symptoms.
- Diagnosis relies on detecting cancer cells in cerebrospinal fluid (CSF) via cytopathological examination.
- Palliative care can improve quality of life and survival despite the generally poor prognosis.
Observation:
- A patient presented with vertigo, tinnitus, and hearing loss, progressing to diffuse facial nerve paralysis.
- Cerebrospinal fluid analysis confirmed carcinomatous meningitis.
- Extensive investigations failed to identify the primary tumor's origin.
Findings:
- This is the first reported English-language case of carcinomatous meningitis originating from a carcinoma of unknown primary.
- The patient's symptoms, including cranial nerve palsies, were indicative of leptomeningeal metastasis.
- Diagnostic confirmation was achieved through CSF cytology.
Implications:
- CM from an unknown primary presents unique diagnostic and management challenges.
- This case underscores the importance of considering leptomeningeal metastasis even when a primary tumor is not evident.
- Further research into the mechanisms and optimal treatment of CM from unknown primaries is warranted.
Related Concept Videos
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...